RFK Jr.’s HHS Nomination Sparks Rally in Dental Stocks as Investors Eye Fluoride Policy Shakeup
Henry Schein and other dental supply companies saw significant gains following news of Robert F. Kennedy Jr.’s nomination as secretary of the Department of Health and Human Services. Market speculation that Kennedy may push to eliminate fluoride from drinking water has investors betting on increased demand for dental care products.
Shares of dental care companies surged on November 18 as markets reacted to President-Elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Henry Schein, a major supplier of dental products, rose 7.5% — its best performance since 2022 — while competitors Dentsply Sirona and Envista also saw notable gains.
The rally stems from speculation that Kennedy, a vocal critic of fluoride in drinking water, might recommend its removal at the national level. Fluoridation, which has long been a cornerstone of public health for reducing caries, has also faced controversy, with some communities opting to discontinue its use. Should fluoride be removed more widely, experts predict a rise in tooth decay, potentially driving higher demand for dental care and products.
Market analysts, such as Gordon Haskett’s Don Bilson, have pointed out that such a policy shift would be a boon for dental companies, as consumers turn to other means to prevent caries.
The stock rally came despite broader declines across the healthcare sector, where Kennedy’s anti-vaccine stance and criticism of pharmaceutical companies raised concerns for drugmakers and insurers. While Kennedy’s nomination still requires Senate confirmation, investors are already preparing for potential regulatory changes under his leadership. Click here to read more.
